Consonance Capital Management’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-137,000
| Closed | -$1.52M | – | 8 |
|
|
2022
Q1 | $1.52M | Sell |
137,000
-13,000
| -9% | -$144K | 2.58% | 7 |
|
|
2021
Q4 | $1.48M | Hold |
150,000
| – | – | 0.97% | 12 |
|
|
2021
Q3 | $1.49M | Hold |
150,000
| – | – | 0.82% | 14 |
|
|
2021
Q2 | $1.55M | Hold |
150,000
| – | – | 0.19% | 30 |
|
|
2021
Q1 | $1.53M | Hold |
150,000
| – | – | 0.16% | 35 |
|
|
2020
Q4 | $1.69M | Buy |
+150,000
| New | +$1.69M | 0.16% | 34 |
|